HCG
Healthcare Global Enterprises Limited (HCG) Stock Analysis
Healthcare Global Enterprises Limited is an Indian cancer-care hospital chain operating multidisciplinary oncology centers. It provides radiation, surgical, and medical oncology services. The company serves patients across South and Central India. It is listed on Indian stock exchanges.
Healthcare › Medical Care Facilities
₹702.10
+1.18% 1W | +8.90% 52W
Market Cap
10.5k CR
P/E Ratio
450.1
52W High
₹804.6
52W Low
₹513.3
Div. Yield
0%
Beta
-0
50 DMA
₹692.6
200 DMA
₹630.1
Profit Margin
0.9%
Inst. Own.
19.4%
⚡ APPROACHING SUPPORT
⚡ APPROACHING SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 461 | 487 | 470 | 495 | 526 | 554 | 559 | 585 | 613 | 647 | 633 | 652 | 695 |
| Expenses | 386 | 402 | 391 | 403 | 435 | 451 | 470 | 480 | 505 | 524 | 524 | 527 | 573 |
| Operating Profit | 74 | 85 | 79 | 92 | 91 | 102 | 88 | 106 | 108 | 123 | 110 | 125 | 122 |
| OPM % | 16% | 17% | 17% | 19% | 17% | 18% | 16% | 18% | 18% | 19% | 17% | 19% | 18% |
| Other Income | 3 | 3 | 6 | 9 | 9 | 11 | 6 | 10 | 8 | 3 | -10 | -18 | 13 |
| Interest | 26 | 27 | 29 | 27 | 34 | 36 | 41 | 44 | 45 | 44 | 45 | 43 | 40 |
| Depreciation | 41 | 43 | 44 | 46 | 47 | 50 | 57 | 58 | 58 | 63 | 61 | 63 | 70 |
| Profit before tax | 11 | 18 | 11 | 28 | 19 | 28 | -3 | 14 | 12 | 20 | -6 | 1 | 25 |
| Tax % | 65% | 40% | 69% | 17% | 28% | 25% | -335% | 50% | 50% | -4% | 30% | -223% | 34% |
| Net Profit | 4 | 11 | 3 | 23 | 14 | 21 | 8 | 7 | 6 | 21 | -8 | 4 | 16 |
| EPS in Rs | 0.52 | 0.92 | 0.39 | 1.44 | 0.82 | 1.22 | 0.47 | 0.50 | 0.32 | 1.09 | -0.63 | 0.15 | 0.92 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 519 | 584 | 700 | 829 | 976 | 1,092 | 1,009 | 1,395 | 1,691 | 1,908 | 2,218 | 2,538 | 2,627 |
| Expenses | 443 | 499 | 595 | 713 | 864 | 936 | 887 | 1,161 | 1,394 | 1,581 | 1,835 | 2,080 | 2,147 |
| Operating Profit | 76 | 85 | 105 | 116 | 112 | 157 | 122 | 234 | 297 | 327 | 384 | 459 | 480 |
| OPM % | 15% | 15% | 15% | 14% | 11% | 14% | 12% | 17% | 18% | 17% | 17% | 18% | 18% |
| Other Income | 0 | -2 | 10 | 25 | 10 | 10 | -72 | 110 | 15 | 24 | 39 | -11 | -13 |
| Interest | 34 | 38 | 23 | 42 | 70 | 138 | 119 | 98 | 104 | 109 | 155 | 177 | 171 |
| Depreciation | 39 | 44 | 57 | 71 | 85 | 148 | 159 | 158 | 163 | 174 | 211 | 244 | 257 |
| Profit before tax | 3 | 0 | 35 | 27 | -33 | -119 | -229 | 88 | 45 | 68 | 57 | 27 | 40 |
| Tax % | -56% | -730% | 34% | 38% | -7% | 5% | -3% | 56% | 61% | 39% | 14% | 15% | |
| Net Profit | 5 | 2 | 23 | 17 | -31 | -125 | -221 | 39 | 18 | 41 | 49 | 23 | 33 |
| EPS in Rs | 0.11 | -0.16 | 2.44 | 2.23 | -2.66 | -11.36 | -14.58 | 3.65 | 1.99 | 3.27 | 3.01 | 0.92 | 1.53 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 14.0% | 20.0% | 16.0% |
| Profit CAGR | -1.0% | 18.0% | 39.0% |
Shareholding Pattern
Promoters62.46%
FIIs2.16%
DIIs13.22%
Public22.17%
Promoters63.78%
FIIs3.59%
DIIs18.36%
Public14.28%
Promoters63.77%
FIIs3.22%
DIIs18.30%
Public14.71%
Promoters64.21%
FIIs2.76%
DIIs18.91%
Public14.15%
Promoters64.21%
FIIs2.73%
DIIs19.20%
Public13.86%
Promoters71.37%
FIIs6.37%
DIIs5.53%
Public16.71%
Promoters71.28%
FIIs6.74%
DIIs8.52%
Public13.45%
Promoters71.22%
FIIs2.44%
DIIs12.48%
Public13.86%
Promoters64.21%
FIIs2.76%
DIIs18.91%
Public14.15%
Promoters64.21%
FIIs2.73%
DIIs19.20%
Public13.86%
HCG
Holdings Analysis
Key strengths & risk signals
68
Overall
59
Fundamental
77
Technical
Risks (2)
Cannot calculate PEG - insufficient growth data.
POSITIVE YEAR! Stock gained 8.9% in the last year.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (692.6) is above 200-day average (630.1) - positive signal.
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 240,128 vs down days: 139,343. Ratio: 1.72x
STRONG POSITION! Current price (702.1) is above both moving averages.
Fundamental & Technical Analysis
68Overall
59Fundamental
77Technical
Fundamental Breakdown
Growth Quality
13/30
Revenue CAGR: 14.6% (GOOD, 11/15). Profit CAGR: -22.3% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 0.9% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 15.59% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (692.6) is above 200-day average (630.1) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (702.1) is above both moving averages.
Trend Pattern
10/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
4/10
POSITIVE YEAR! Stock gained 8.9% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 240,128 vs down days: 139,343. Ratio: 1.72x
RSI
3/5
NEUTRAL! RSI at 52.6 - balanced momentum.
52W Range
4/5
UPPER HALF! Trading at 64.8% of 52W range - positive territory.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - 1.2% (1 week), -1.4% (1 month), 16.0% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
HCG
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-10 | Concall PDF | |
| Q4FY262026-05-26 | Concall PDF | |
| Q3FY262026-02-13 | Concall PDF | |
| Q2FY262025-12-11 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCG | ₹702.10 | 450.1 | 0.9% | 14.6% | -22.3% | +8.9% | 68 | APPROACHING SUPPORT | +187.5% | +527.3% | +13.3% | +6.6% |
| YATHARTH | ₹1,125.30 | 60.2 | 13.2% | 32.0% | 38.7% | +47.2% | 88 | BREAKOUT | +12.1% | -0.8% | +51.5% | +15.0% |
| JLHL | ₹276.00 | 48.3 | 12.0% | 18.9% | 38.6% | -5.3% | 62 | APPROACHING SUPPORT | -14.6% | -25.9% | +16.4% | +6.0% |
| PARKHOSPS | ₹284.70 | 43.5 | 16.1% | 9.6% | 5.5% | +90.6% | 68 | APPROACHING RESISTANCE | +42.2% | +16.4% | +19.3% | +3.3% |
| NEPHROPLUS | ₹751.50 | 88.7 | 8.1% | 33.9% | – | +57.7% | 73 | CONSOLIDATING UP | +35.0% | +5.3% | +23.7% | +6.1% |
| KOVAI | ₹6,195.00 | 26.5 | 15.6% | 18.2% | 28.3% | +141.6% | 76 | APPROACHING RESISTANCE | +20.8% | +15.7% | +15.3% | +4.3% |
| RAINBOW | ₹1,438.70 | 51.2 | 15.7% | 13.1% | 9.7% | +3.2% | 69 | APPROACHING SUPPORT | +13.3% | -21.3% | +33.2% | +2.2% |
| JSLL | ₹508.00 | 26.8 | 27.8% | 57.7% | 87.3% | -37.6% | 64 | BOUNCE FROM SUPPORT | +28.5% | +46.1% | +28.7% | +4.1% |
Data from TradeAlone · Updated daily
HCG News
Healthcare Global Enterprises Limited (NSE: HCG) clears resistance, gains 5% intraday2026-08-10Healthcare Global Enterprises Limited Q1 FY27: Revenue Up 13%, Adjusted Ebitda Grows 20%2026-08-06Healthcare Global Enterprises Limited (HCG) shows pressure after breakout, falls 5% intraday2026-07-15Healthcare Global Enterprises Limited (NSE: HCG) climbs 5% intraday2026-06-30Healthcare Global Enterprises Limited (HCG) Launches Cancer Hospital in North Bengaluru2026-05-19
